{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T10:58:56Z","timestamp":1777114736905,"version":"3.51.4"},"reference-count":52,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T00:00:00Z","timestamp":1767052800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Preeclampsia (PE) is closely associated with dyslipidemia and inflammatory imbalance. High-density lipoprotein (HDL)-related inflammatory indices have demonstrated predictive potential in cardiovascular and metabolic diseases, but evidence regarding their role in PE remains limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aimed to investigate the associations between early-pregnancy HDL-related inflammatory indices, including the lymphocyte-to-HDL ratio (LHR), monocyte-to-HDL ratio (MHR), neutrophil-to-HDL ratio (NHR), and platelet-to-HDL ratio (PHR), and the risk of PE.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 5,959 women with singleton pregnancies were retrospectively included. All participants underwent complete blood counts (CBC) and lipid profiling at 11\u201313 weeks of gestation, from which HDL-related inflammatory indices were calculated. Associations between these indices and PE risk were systematically evaluated using modified Poisson regression, restricted cubic splines (RCS), subgroup analyses, and sensitivity analyses. To assess their potential clinical utility, prediction models incorporating HDL-related inflammatory indices were developed and evaluated using receiver operating characteristic (ROC) curves, calibration plots, and decision curve analysis (DCA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 5,959 participants, 124 (2.08%) developed PE. Multivariable-adjusted analyses revealed that higher levels of LHR (RR\u2009=\u20091.99, 95% CI: 1.17\u20133.42,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.012), MHR (RR\u2009=\u20092.62, 95% CI: 1.58\u20134.35,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001), NHR (RR\u2009=\u20092.87, 95% CI: 1.64\u20135.02,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001), and PHR (RR\u2009=\u20092.57, 95% CI: 1.48\u20134.48,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001) were significantly associated with increased PE risk. Quartile analyses demonstrated a dose-response relationship across categories (\n                      <jats:italic>P<\/jats:italic>\n                      for trend\u2009&lt;\u20090.05). RCS revealed U-shaped associations for LHR (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.008) and NHR (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.048), which became approximately linear after excluding extreme values. Subgroup analyses suggested stronger associations in women with gestational diabetes mellitus (GDM), advanced maternal age, or higher BMI, indicating potential effect modification. Sensitivity analyses confirmed the consistency of these associations. Incorporation of these indices modestly improved model discrimination (AUC 0.697) and provided limited clinical benefit in DCA.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec005\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Early-pregnancy HDL-related inflammatory indices, particularly MHR, NHR, and PHR, are significantly associated with increased PE risk. These indices reflect both lipid metabolism and inflammatory status, offering simple, accessible biomarkers for early risk stratification and potential supplementation of existing PE prediction strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0339322","type":"journal-article","created":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T19:04:06Z","timestamp":1767121446000},"page":"e0339322","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["Early-pregnancy HDL-related inflammatory indices and risk of preeclampsia: A retrospective cohort study"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-1835-1327","authenticated-orcid":true,"given":"Hui","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Lan","family":"Bao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian-Nan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun-Duo","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Qiu","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2025,12,30]]},"reference":[{"issue":"7","key":"pone.0339322.ref001","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1001\/jamacardio.2023.1312","article-title":"Genetic risk factors associated with preeclampsia and hypertensive disorders of pregnancy","volume":"8","author":"JS Tyrmi","year":"2023","journal-title":"JAMA Cardiol"},{"issue":"8","key":"pone.0339322.ref002","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/nrneph.2014.102","article-title":"Pre-eclampsia part 1: current understanding of its pathophysiology","volume":"10","author":"T Chaiworapongsa","year":"2014","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"pone.0339322.ref003","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1161\/HYPERTENSIONAHA.117.10803","article-title":"Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice","volume":"72","author":"MA Brown","year":"2018","journal-title":"Hypertension"},{"issue":"1","key":"pone.0339322.ref004","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25010307","article-title":"Pathophysiology of Pre-Eclampsia-Two Theories of the Development of the Disease","volume":"25","author":"J Kornacki","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"5","key":"pone.0339322.ref005","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1007\/s00404-024-07393-6","article-title":"Advances in pathogenesis of preeclampsia","volume":"309","author":"M Yang","year":"2024","journal-title":"Arch Gynecol Obstet"},{"issue":"6","key":"pone.0339322.ref006","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22063132","article-title":"Insight into the key points of preeclampsia pathophysiology: uterine artery remodeling and the role of microRNAs","volume":"22","author":"K Pankiewicz","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"4","key":"pone.0339322.ref007","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/aje\/kwu145","article-title":"Maternal hyperlipidemia and the risk of preeclampsia: a meta-analysis","volume":"180","author":"CN Spracklen","year":"2014","journal-title":"Am J Epidemiol"},{"issue":"7","key":"pone.0339322.ref008","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.amjhyper.2004.03.666","article-title":"Maternal plasma lipid concentrations in early pregnancy and risk of preeclampsia","volume":"17","author":"DA Enquobahrie","year":"2004","journal-title":"Am J Hypertens"},{"issue":"10","key":"pone.0339322.ref009","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1111\/j.1447-0756.2011.01562.x","article-title":"Serum lipids level assessed in early pregnancy and risk of pre-eclampsia","volume":"37","author":"O Demirci","year":"2011","journal-title":"J Obstet Gynaecol Res"},{"key":"pone.0339322.ref010","doi-asserted-by":"crossref","first-page":"154012","DOI":"10.1016\/j.metabol.2019.154012","article-title":"Effects of preeclampsia and eclampsia on maternal metabolic and biochemical outcomes in later life: a systematic review and meta-analysis","volume":"102","author":"V Alonso-Ventura","year":"2020","journal-title":"Metabolism"},{"key":"pone.0339322.ref011","doi-asserted-by":"crossref","first-page":"102080","DOI":"10.1016\/j.plefa.2020.102080","article-title":"Maternal dietary fatty acids and their roles in human placental development","volume":"155","author":"AK Duttaroy","year":"2020","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"pone.0339322.ref012","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.placenta.2020.03.007","article-title":"Maternal hypercholesterolemia during pregnancy: potential modulation of cholesterol transport through the human placenta and lipoprotein profile in maternal and neonatal circulation","volume":"94","author":"C Cantin","year":"2020","journal-title":"Placenta"},{"issue":"10","key":"pone.0339322.ref013","doi-asserted-by":"crossref","DOI":"10.3390\/nu14102087","article-title":"An overview of obesity, cholesterol, and systemic inflammation in preeclampsia","volume":"14","author":"MC Alston","year":"2022","journal-title":"Nutrients"},{"issue":"12","key":"pone.0339322.ref014","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1046\/j.1365-2362.2000.00753.x","article-title":"The use of platelet density and volume measurements to estimate the severity of pre-eclampsia","volume":"30","author":"P J\u00e4remo","year":"2000","journal-title":"Eur J Clin Invest"},{"issue":"2","key":"pone.0339322.ref015","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1161\/HYPERTENSIONAHA.117.10182","article-title":"Meta-analysis and systematic review to assess the role of soluble FMS-Like tyrosine kinase-1 and placenta growth factor ratio in prediction of preeclampsia: the SaPPPhirE study","volume":"71","author":"S Agrawal","year":"2018","journal-title":"Hypertension"},{"issue":"1","key":"pone.0339322.ref016","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0002-9378(98)70254-6","article-title":"Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis","volume":"179","author":"GP Sacks","year":"1998","journal-title":"Am J Obstet Gynecol"},{"issue":"10","key":"pone.0339322.ref017","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1055\/s-0029-1223285","article-title":"Increased neutrophil numbers account for leukocytosis in women with preeclampsia","volume":"26","author":"BJ Canzoneri","year":"2009","journal-title":"Am J Perinatol"},{"issue":"2","key":"pone.0339322.ref018","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1081\/PRG-120021059","article-title":"Neutrophil activation and C-reactive protein concentration in preeclampsia","volume":"22","author":"L Belo","year":"2003","journal-title":"Hypertens Pregnancy"},{"issue":"1","key":"pone.0339322.ref019","doi-asserted-by":"crossref","first-page":"15469","DOI":"10.1038\/s41598-022-19847-5","article-title":"Distinct gene expression patterns for CD14++ and CD16++ monocytes in preeclampsia","volume":"12","author":"P Vishnyakova","year":"2022","journal-title":"Sci Rep"},{"issue":"4","key":"pone.0339322.ref020","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1515\/jpm-2018-0286","article-title":"Characterization of fetal monocytes in preeclampsia and fetal growth restriction","volume":"47","author":"TI Alahakoon","year":"2019","journal-title":"J Perinat Med"},{"issue":"2","key":"pone.0339322.ref021","doi-asserted-by":"crossref","first-page":"838","DOI":"10.4103\/jfmpc.jfmpc_1528_20","article-title":"Role of platelet count and mean platelet volume and red cell distribution width in the prediction of preeclampsia in early pregnancy","volume":"10","author":"Vandana","year":"2021","journal-title":"J Family Med Prim Care"},{"issue":"7","key":"pone.0339322.ref022","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1080\/01443615.2022.2109136","article-title":"Association between platelet indices and risk of preeclampsia in pregnant women","volume":"42","author":"J Wu","year":"2022","journal-title":"J Obstet Gynaecol"},{"issue":"2","key":"pone.0339322.ref023","article-title":"Elevated neutrophil, lymphocyte, and platelet counts as early biomarkers of preeclampsia risk: a retrospective cohort study","volume":"94","author":"Y-L Yao","year":"2025","journal-title":"Am J Reprod Immunol"},{"issue":"2","key":"pone.0339322.ref024","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/uog.26032","article-title":"Clinical utility of sFlt-1 and PlGF in screening, prediction, diagnosis and monitoring of pre-eclampsia and fetal growth restriction","volume":"61","author":"H Stepan","year":"2023","journal-title":"Ultrasound Obstet Gynecol"},{"key":"pone.0339322.ref025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2020.07.020","article-title":"First trimester preeclampsia screening and prediction","volume":"226","author":"P Chaemsaithong","year":"2022","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"pone.0339322.ref026","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1414838","article-title":"Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia","volume":"374","author":"H Zeisler","year":"2016","journal-title":"N Engl J Med"},{"issue":"1","key":"pone.0339322.ref027","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12944-024-02411-7","article-title":"Association between lymphocyte to high-density lipoprotein cholesterol ratio and insulin resistance and metabolic syndrome in US adults: results from NHANES 2007-2018","volume":"24","author":"J Guo","year":"2025","journal-title":"Lipids Health Dis"},{"key":"pone.0339322.ref028","doi-asserted-by":"crossref","first-page":"1372731","DOI":"10.3389\/fcell.2024.1372731","article-title":"Association between monocyte-to-lymphocyte ratio and prostate cancer in the U.S. population: a population-based study","volume":"12","author":"L Wang","year":"2024","journal-title":"Front Cell Dev Biol"},{"issue":"3","key":"pone.0339322.ref029","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1007\/s10753-024-02111-5","article-title":"Correction: lymphocyte to high-density lipoprotein cholesterol ratio is positively associated with pre-diabetes, metabolic syndrome, and non-traditional cardiometabolic risk markers: a cross-sectional study at secondary health care","volume":"48","author":"FG C\u00e2ndido","year":"2025","journal-title":"Inflammation"},{"issue":"1","key":"pone.0339322.ref030","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12944-022-01638-6","article-title":"Monocyte-to-high-density lipoprotein-cholesterol ratio (MHR) and the risk of all-cause and cardiovascular mortality: a nationwide cohort study in the United States","volume":"21","author":"M Jiang","year":"2022","journal-title":"Lipids Health Dis"},{"issue":"3","key":"pone.0339322.ref031","article-title":"Association of three novel inflammatory markers: lymphocyte to HDL-C ratio, high-sensitivity C-reactive protein to HDL-C ratio and high-sensitivity C-reactive protein to lymphocyte ratio with metabolic syndrome","volume":"7","author":"R Kolahi Ahari","year":"2024","journal-title":"Endocrinol Diabetes Metab"},{"key":"pone.0339322.ref032","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.2147\/JIR.S458950","article-title":"Impact of platelet-to-HDL-cholesterol ratio on long-term mortality in coronary artery disease patients with or without type 2 diabetes: insights from a chinese multicenter cohort","volume":"17","author":"W Wu","year":"2024","journal-title":"J Inflamm Res"},{"issue":"19","key":"pone.0339322.ref033","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e38829","article-title":"Neutrophil-to-HDL-C Ratio as an inflammatory biomarker in patients with anxiety and obstructive coronary artery disease: a retrospective study","volume":"10","author":"A Zhang","year":"2024","journal-title":"Heliyon"},{"issue":"5","key":"pone.0339322.ref034","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1002\/uog.22107","article-title":"Cardiovascular events following pregnancy complicated by pre-eclampsia with emphasis on comparison between early- and late-onset forms: systematic review and meta-analysis","volume":"57","author":"A Dall\u2019Asta","year":"2021","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"9","key":"pone.0339322.ref035","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1038\/s41591-023-02510-5","article-title":"Cell-free DNA methylome analysis for early preeclampsia prediction","volume":"29","author":"M De Borre","year":"2023","journal-title":"Nat Med"},{"issue":"6","key":"pone.0339322.ref036","article-title":"Gestational hypertension and preeclampsia: ACOG practice bulletin, number 222","volume":"135","year":"2020","journal-title":"Obstet Gynecol"},{"issue":"4","key":"pone.0339322.ref037","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1097\/AOG.0000000000000451","article-title":"Clinical risk factors for preeclampsia in the 21st century","volume":"124","author":"E Par\u00e9","year":"2014","journal-title":"Obstet Gynecol"},{"issue":"5","key":"pone.0339322.ref038","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.8401","article-title":"Preeclampsia prevalence, risk factors, and pregnancy outcomes in Sweden and China","volume":"4","author":"Y Yang","year":"2021","journal-title":"JAMA Netw Open"},{"key":"pone.0339322.ref039","article-title":"Clinical risk factors for pre-eclampsia determined in early pregnancy: systematic review and meta-analysis of large cohort studies","volume":"353","author":"High Risk of Pre-eclampsia Identification Group","year":"2016","journal-title":"BMJ"},{"issue":"8","key":"pone.0339322.ref040","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1111\/1471-0528.15661","article-title":"Impact of maternal body mass index and gestational weight gain on pregnancy complications: an individual participant data meta-analysis of European, North American and Australian cohorts","volume":"126","author":"S Santos","year":"2019","journal-title":"BJOG"},{"issue":"17","key":"pone.0339322.ref041","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1001\/jama.2019.3820","article-title":"Association of gestational weight gain with adverse maternal and infant outcomes","volume":"321","author":"LifeCycle Project-Maternal Obesity and Childhood Outcomes Study Group","year":"2019","journal-title":"JAMA"},{"key":"pone.0339322.ref042","article-title":"Hyperglycaemia and risk of adverse perinatal outcomes: systematic review and meta-analysis","volume":"354","author":"D Farrar","year":"2016","journal-title":"BMJ"},{"issue":"3","key":"pone.0339322.ref043","article-title":"Association of ambient air pollutant mixtures with IVF\/ICSI-ET clinical pregnancy rates during critical exposure periods","volume":"2024","author":"R-L Liu","year":"2024","journal-title":"Hum Reprod Open"},{"issue":"2","key":"pone.0339322.ref044","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jri.2012.01.006","article-title":"The predominance of Th17 lymphocytes and decreased number and function of Treg cells in preeclampsia","volume":"93","author":"D Darmochwal-Kolarz","year":"2012","journal-title":"J Reprod Immunol"},{"issue":"1","key":"pone.0339322.ref045","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1365-2249.2011.04493.x","article-title":"Pregnancy-associated diseases are characterized by the composition of the systemic regulatory T cell (Treg) pool with distinct subsets of Tregs","volume":"167","author":"A Steinborn","year":"2012","journal-title":"Clin Exp Immunol"},{"key":"pone.0339322.ref046","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.preghy.2020.06.002","article-title":"Increased TLR4 pathway activation and cytokine imbalance led to lipopolysaccharide tolerance in monocytes from preeclamptic women","volume":"21","author":"M Rom\u00e3o-Veiga","year":"2020","journal-title":"Preg Hypertens"},{"issue":"4","key":"pone.0339322.ref047","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1447-0756.2007.00551.x","article-title":"TNF-alpha from monocyte of patients with pre-eclampsia-induced apoptosis in human trophoblast cell line","volume":"33","author":"H Seki","year":"2007","journal-title":"J Obstet Gynaecol Res"},{"issue":"6","key":"pone.0339322.ref048","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1053\/plac.2001.0691","article-title":"Neutrophil activation induced by placental factors in normal and pre-eclamptic pregnancies in vitro","volume":"22","author":"Y Wang","year":"2001","journal-title":"Placenta"},{"key":"pone.0339322.ref049","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.placenta.2019.06.384","article-title":"Both \u201ccanonical\u201d and \u201cimmunological\u201d preeclampsia subtypes demonstrate changes in placental immune cell composition","volume":"83","author":"K Leavey","year":"2019","journal-title":"Placenta"},{"issue":"4","key":"pone.0339322.ref050","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1042\/BST20140310","article-title":"Elevated venous thromboembolism risk in preeclampsia: molecular mechanisms and clinical impact","volume":"43","author":"K Egan","year":"2015","journal-title":"Biochem Soc Trans"},{"issue":"2","key":"pone.0339322.ref051","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1182\/blood-2005-02-0491","article-title":"Platelet-derived soluble factors induce human extravillous trophoblast migration and differentiation: platelets are a possible regulator of trophoblast infiltration into maternal spiral arteries","volume":"106","author":"Y Sato","year":"2005","journal-title":"Blood"},{"issue":"7","key":"pone.0339322.ref052","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/j.jtha.2023.03.014","article-title":"Overexpression of facilitative glucose transporter-3 and membrane procoagulation in maternal platelets of preeclamptic pregnancy","volume":"21","author":"EO Agbani","year":"2023","journal-title":"J Thromb Haemost"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0339322","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T19:04:13Z","timestamp":1767121453000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0339322"}},"subtitle":[],"editor":[{"given":"Erfan","family":"Ghadirzadeh","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2025,12,30]]},"references-count":52,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12,30]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0339322","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,30]]}}}